The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Neoadjuvant chemotherapy versus neoadjuvant hormonal therapy in postmenopausal women with ER-positive, HER2/neu negative locally advanced breast cancer.
Tadeu Frantz Ambros
No relevant relationships to disclose
Isildinha M. Reis
No relevant relationships to disclose
Dilprit Bagga
No relevant relationships to disclose
Jose Caetano Villasboas
No relevant relationships to disclose
Clifford Blieden
No relevant relationships to disclose
Victoria Sujoy
No relevant relationships to disclose
Jean L. Wright
No relevant relationships to disclose
Kunal Saigal
No relevant relationships to disclose
Carmen Gomez Fernandez
No relevant relationships to disclose
Judith Hurley
No relevant relationships to disclose